Retinal abnormalities may indicate preclinical Alzheimer's

Retinal abnormalities may indicate preclinical alzheimer's

(HealthDay)—Retinal microvascular abnormalities are identified in cognitively healthy individuals who have biomarkers positive for Alzheimer's disease (AD), according to a study published online Aug. 23 in JAMA Ophthalmology.

Bliss Elizabeth O'Bryhim, M.D., Ph.D., from Washington University in St. Louis, and colleagues conducted a case-control study involving 32 cognitively normal participants who underwent and/or cerebral spinal fluid testing to determine biomarker status. Using an optical coherence tomographic angiography system, automated measurements of retinal nerve fiber layer thickness, ganglion cell layer thickness, inner and outer foveal thickness, vascular density, macular volume, and foveal avascular zone were collected for both eyes.

The analysis included 58 eyes from 30 participants (one African-American and 29 white). Fourteen participations had biomarkers positive for AD and were included as the preclinical AD group, while 16 without biomarkers served as the control group. The researchers found that, compared with controls, the foveal avascular zone was increased in the biomarker-positive group (mean, 0.364 versus 0.275 mm²). In the -positive group, mean inner foveal thickness was decreased (66.0 versus 75.4 µm).

"We know the pathology of Alzheimer's disease starts to develop years before symptoms appear, but if we could use this eye test to notice when the pathology is beginning, it may be possible one day to start treatments sooner to delay further damage," a coauthor said in a statement.

The study was funded in part by an educational grant from Optovue.

More information: Abstract/Full Text
Editorial (subscription or payment may be required)

Journal information: JAMA Ophthalmology

Copyright © 2018 HealthDay. All rights reserved.

Citation: Retinal abnormalities may indicate preclinical Alzheimer's (2018, August 28) retrieved 21 May 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Alzheimer's one day may be predicted during eye exam


Feedback to editors